These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography. Yari S, Hadizadeh Tasbiti A, Ghanei M, Shokrgozar MA, Fateh A, Mahdian R, Yari F, Bahrmand A. Arch Microbiol; 2017 Jan; 199(1):9-15. PubMed ID: 27417316 [Abstract] [Full Text] [Related]
23. A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis. Defelipe LA, Do Porto DF, Pereira Ramos PI, Nicolás MF, Sosa E, Radusky L, Lanzarotti E, Turjanski AG, Marti MA. Tuberculosis (Edinb); 2016 Mar; 97():181-92. PubMed ID: 26791267 [Abstract] [Full Text] [Related]
29. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products. Prasasty VD, Cindana S, Ivan FX, Zahroh H, Sinaga E. Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965 [Abstract] [Full Text] [Related]
30. Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis. Zhao J, Wei W, Yan H, Zhou Y, Li Z, Chen Y, Zhang C, Zeng J, Chen T, Zhou L. Int J Med Microbiol; 2019 Nov; 309(7):151323. PubMed ID: 31279617 [Abstract] [Full Text] [Related]